Evidence map›Paper›PMID 28115521›Full record

ArticleThe Journal of biological chemistry2017

Platelet Factor 4 Binds to Vascular Proteoglycans and Controls Both Growth Factor Activities and Platelet Activation.

Megan S Lord, Bill Cheng, Brooke L Farrugia, Simon McCarthy, John M Whitelock

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 81 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. The winding road to platelet α-granules.Frontiers in cell and developmental biology · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. ZnInternational journal of molecular sciences · 2023
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Megan S LordFrom the Graduate School of Biomedical Engineering, University of New South Wales, Sydney, New South Wales 2052, Australia and m.lord@unsw.edu.au.
Bill ChengFrom the Graduate School of Biomedical Engineering, University of New South Wales, Sydney, New South Wales 2052, Australia and.
Brooke L FarrugiaFrom the Graduate School of Biomedical Engineering, University of New South Wales, Sydney, New South Wales 2052, Australia and.
Simon McCarthythe Tricol Biomedical, Portland, Oregon 97205.
John M WhitelockFrom the Graduate School of Biomedical Engineering, University of New South Wales, Sydney, New South Wales 2052, Australia and.
UNSW Sydney · AUTricol Biomedical (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Platelet factor 4 (PF4) is produced by platelets with roles in both inflammation and wound healing. PF4 is stored in platelet α-granules bound to the glycosaminoglycan (GAG) chains of serglycin. This study revealed that platelet serglycin is decorated with chondroitin/dermatan sulfate and that PF4 binds to these GAG chains. Additionally, PF4 had a higher affinity for endothelial-derived perlecan heparan sulfate chains than serglycin GAG chains. The binding of PF4 to perlecan was found to inhibit both FGF2 signaling and platelet activation. This study revealed additional insight into the ways in which PF4 interacts with components of the vasculature to modulate cellular events.

Indexed as

Blood PlateletsBlotting, WesternChondroitin SulfatesDermatan SulfateFibroblast Growth Factor 2Heparan SulfateHeparan Sulfate ProteoglycansHumansPlatelet ActivationPlatelet Factor 4Protein BindingProteoglycansVesicular Transport ProteinsChondroitin SulfatesDermatan SulfateFibroblast Growth Factor 2Heparan SulfateHeparan Sulfate ProteoglycansperlecanPlatelet Factor 4ProteoglycansserglycinVesicular Transport Proteinsextracellular matrix proteinglycosaminoglycanheparan sulfateperlecanproteoglycanproteoglycan structureserglycin

Identifiers

PMID28115521
PMCPMC5354495
OpenAlexW2580490670

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.